USFDA completes inspection at Caplin Point Lab's sterile injectable facility in Tamil Nadu

"The United States Food and Drug Administration (USFDA) has conducted an inspection at our sterile injectable site (CP-IV) located at Gummudipoondi from August 30 to September 06, 2018," Caplin Point Laboratories said in a BSE filing.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2Cr4NHq
via IFTTT